PRINCETON, NJ, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (SONN), a clinical-stage company developing targeted immunotherapeutic drugs, announced today that it has entered ...
LEXINGTON, Mass., July 2, 2025 /PRNewswire/ -- Curis, Inc. (CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, ...
60 Degrees Pharmaceuticals closed a direct stock offering, raising approximately $1.075 million for working capital and corporate purposes. 60 Degrees Pharmaceuticals, Inc. has completed a registered ...
LONDON, UNITED KINGDOM, March 7, 2023 /EINPresswire.com/ -- Direct Placements, a London-based recruitment firm, aims to level the playing field for graduates who are ...